Thoracic Cancer Beyond the Clinic - Community Impacts is organized by American Society for Radiation Oncology (ASTRO).
Course Opens: 01/31/2022
Course Expires: 01/30/2025
Description:
Covid-19 rapidly affected our lives and the life of our patients. Vaccination campaign started in 2021. At least four types of vaccines are widely used in the US (Pfizer, Moderna, Johnson and Johnson and Astra Zeneca). Speakers review the data in the general population and available data in the cancer population. In general, the activity of the vaccines are similar for patients with solid tumors and the normal population. Possible influencing factor are chemotherapy, use of steroids and age. Data on larger cohort of patients with lung cancer are lacking.
Topics of discussions are:
An additional presentation is regarding topics related with advanced precision diagnostics in the context of patients with thoracic malignancies. The presentation offers an update of optimal strategies to assess molecular biomarkers in tumor tissue samples and their impact in patient care.
Learning Objectives:
Upon completion of this activity, participants should be able to:
Accreditation
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
1.50 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
1.50 Certificate of Attendance
This activity was designated for 1.50 AMA PRA Category 1 Credit™.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved